NO2533774T3 - - Google Patents

Info

Publication number
NO2533774T3
NO2533774T3 NO11708533A NO11708533A NO2533774T3 NO 2533774 T3 NO2533774 T3 NO 2533774T3 NO 11708533 A NO11708533 A NO 11708533A NO 11708533 A NO11708533 A NO 11708533A NO 2533774 T3 NO2533774 T3 NO 2533774T3
Authority
NO
Norway
Application number
NO11708533A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO2533774T3 publication Critical patent/NO2533774T3/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO11708533A 2010-02-11 2011-02-10 NO2533774T3 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1000560A FR2956031B1 (fr) 2010-02-11 2010-02-11 Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement du trouble obsessionnel compulsif (toc)
PCT/FR2011/000080 WO2011098689A2 (fr) 2010-02-11 2011-02-10 Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement du trouble obsessionnel compulsif (toc)

Publications (1)

Publication Number Publication Date
NO2533774T3 true NO2533774T3 (el) 2018-06-30

Family

ID=42244669

Family Applications (1)

Application Number Title Priority Date Filing Date
NO11708533A NO2533774T3 (el) 2010-02-11 2011-02-10

Country Status (34)

Country Link
US (1) US20120309838A1 (el)
EP (1) EP2533774B1 (el)
JP (1) JP5634529B2 (el)
KR (1) KR20120117936A (el)
CN (1) CN102781437B (el)
AR (1) AR080150A1 (el)
AU (1) AU2011214190B2 (el)
BR (1) BR112012020169A2 (el)
CA (1) CA2789082C (el)
CY (1) CY1120009T1 (el)
DK (1) DK2533774T3 (el)
EA (1) EA023473B1 (el)
ES (1) ES2667856T3 (el)
FR (1) FR2956031B1 (el)
GE (1) GEP20166456B (el)
HK (1) HK1177897A1 (el)
HR (1) HRP20180537T1 (el)
HU (1) HUE037098T2 (el)
LT (1) LT2533774T (el)
MA (1) MA34129B1 (el)
ME (1) ME03047B (el)
MX (1) MX2012009087A (el)
MY (1) MY158112A (el)
NO (1) NO2533774T3 (el)
NZ (1) NZ601452A (el)
PL (1) PL2533774T3 (el)
PT (1) PT2533774T (el)
RS (1) RS56932B1 (el)
SG (1) SG182748A1 (el)
SI (1) SI2533774T1 (el)
TR (1) TR201802155T4 (el)
UA (1) UA104368C2 (el)
WO (1) WO2011098689A2 (el)
ZA (1) ZA201205566B (el)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2810656B1 (en) * 2013-06-06 2017-08-02 Zentiva, a.s. Agomelatine formulations comprising agomelatine in the form of co-crystals
CN103655499B (zh) * 2013-12-23 2015-07-22 天津泰普药品科技发展有限公司 一种稳定的晶x型阿戈美拉汀片剂及其制备方法
KR102039582B1 (ko) 2018-12-12 2019-11-01 주식회사 라파스 인장 공정으로 제조하기에 적합한 마이크로니들 재료의 적합성 시험 방법 및 이를 포함하는 마이크로니들 제조 방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658818B1 (fr) 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5618824A (en) * 1994-03-09 1997-04-08 Merrell Pharmaceuticals Inc. Treatment of obsessive-compulsive disorders with 5-HT2 antagonists
AR047553A1 (es) * 2003-07-04 2006-01-25 Lundbeck & Co As H La combinacion de un inhibidor de reabsorcion de serotonina y agomelatina
FR2866335B1 (fr) * 2004-02-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'agomelatine
EP1858515A2 (en) * 2005-03-04 2007-11-28 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
FR2899472B1 (fr) * 2006-04-07 2008-09-12 Servier Lab Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement du trouble anxiete generalisee
JP2009538331A (ja) * 2006-05-22 2009-11-05 ヴァンダ ファーマシューティカルズ インコーポレイテッド 抑うつ障害のための治療
WO2008035177A2 (en) * 2006-09-18 2008-03-27 Copharm Combination of mt1 and mt2 melatonin receptor agonists and a norepinephrine/dopamine reuptake inhibitor

Also Published As

Publication number Publication date
LT2533774T (lt) 2018-02-26
WO2011098689A2 (fr) 2011-08-18
RS56932B1 (sr) 2018-05-31
CN102781437B (zh) 2014-07-30
AU2011214190B2 (en) 2013-04-18
SG182748A1 (en) 2012-08-30
JP5634529B2 (ja) 2014-12-03
EA201201123A1 (ru) 2013-03-29
HUE037098T2 (hu) 2018-08-28
US20120309838A1 (en) 2012-12-06
KR20120117936A (ko) 2012-10-24
EP2533774A2 (fr) 2012-12-19
TR201802155T4 (tr) 2018-03-21
BR112012020169A2 (pt) 2020-11-03
NZ601452A (en) 2014-11-28
WO2011098689A3 (fr) 2011-12-08
ES2667856T3 (es) 2018-05-14
MY158112A (en) 2016-08-30
DK2533774T3 (en) 2018-05-07
ME03047B (me) 2018-10-20
PL2533774T3 (pl) 2018-06-29
EA023473B1 (ru) 2016-06-30
EP2533774B1 (fr) 2018-01-31
MA34129B1 (fr) 2013-04-03
AR080150A1 (es) 2012-03-14
HRP20180537T1 (hr) 2018-05-04
UA104368C2 (ru) 2014-01-27
GEP20166456B (en) 2016-04-11
AU2011214190A1 (en) 2012-08-16
FR2956031A1 (fr) 2011-08-12
SI2533774T1 (en) 2018-05-31
CA2789082C (fr) 2015-11-24
JP2013519659A (ja) 2013-05-30
FR2956031B1 (fr) 2012-03-02
MX2012009087A (es) 2012-09-07
PT2533774T (pt) 2018-02-27
HK1177897A1 (en) 2013-08-30
CN102781437A (zh) 2012-11-14
CY1120009T1 (el) 2018-12-12
CA2789082A1 (fr) 2011-08-18
ZA201205566B (en) 2013-09-25

Similar Documents

Publication Publication Date Title
BR112013008959A2 (el)
BR112012031500A2 (el)
BR112012029986A2 (el)
BR112012030039A2 (el)
BR112012028408A2 (el)
BR112012026492A2 (el)
BR112012027808A2 (el)
BR112012024897A2 (el)
BR112012019354A2 (el)
BR112012025307A2 (el)
BR112012002126A2 (el)
BR112012026946A2 (el)
BR112012017960A2 (el)
BR112012025482A2 (el)
BR112013006400A2 (el)
BR112012031826A2 (el)
BR112012028186A2 (el)
BR112012025577A2 (el)
BR112012023249A2 (el)
BR112012016456A2 (el)
BR112012018256A2 (el)
BR112012027015A2 (el)
BR112012025308A2 (el)
BR112012027945A2 (el)
BR112012024872A2 (el)